Developer docs
API playgroundTry for free, no card

Search company profiles

Formulated Solutions

Full company profile

uuid0008upg

Namestring
Formulated Solutions
Legal namestring
Formulated Solutions, LLC
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Formulated Solutions is a US-based, non-sterile contract development and manufacturing organization (CDMO) founded in 1999 and headquartered in Largo, Florida. The company provides end-to-end services for pharmaceutical, over-the-counter (OTC), medical device, and consumer healthcare brand owners, spanning formulation and analytical development, regulatory affairs, cGMP manufacturing, and packaging. Its product portfolio covers topical creams, gels and ointments, nasal sprays, oral dose liquids, aerosols, bag-on-valve systems, and high-solid powder sprays across Rx, OTC, personal care, and FDA Class 1/2 medical device categories.

The company's technology base rests on three proprietary delivery platforms—eN₂fused™ (whipped microbubble delivery), cryO₂fused® (cryogenic cooling delivery), and ZnOSpray™ (high-solid powder spray)—complemented by container closure systems and high-speed production lines reaching 185–200 units per minute on metered dose nasal sprays. Operating capacity exceeds 650 million units annually across more than 800,000 sq ft of combined cGMP manufacturing and warehousing, anchored by a 220,000 sq ft flagship in Largo, FL and a 455,000 sq ft secondary site in Cleveland, TN acquired in 2023. The company is regulated by FDA and 16 additional global authorities and holds ISO 9001, ISO 13485, ISO 22716, ISO 14001, and ISO 45001 certifications.

Formulated Solutions generates revenue on a fee-for-service contract manufacturing basis, with commercial programs typically requiring minimum order quantities of 50,000–75,000 units per SKU and scaling to tens of millions of units annually under multi-year agreements. The company sells exclusively through a B2B enterprise model targeting brand owners, with go-to-market driven by direct field sales (led by a Chief Commercial Officer and regional representatives) supplemented by industry trade shows (BIO, CPHI, Cosmoprof), thought leadership webinars, and content marketing. Customers include seven of the world's top 12 consumer healthcare companies, and products reach more than 45 countries. The company has been controlled by Linden Capital Partners since 2021, when founder Eric Dann sold a controlling share while retaining a board seat.

Short descriptiontext

Formulated Solutions is a US-based non-sterile CDMO providing end-to-end formulation development, cGMP manufacturing, and packaging services for pharmaceutical, OTC, medical device, and consumer healthcare brand owners across two facilities totaling 800,000+ sq ft.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLargo, United States
HQ citystring
Largo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract development manufacturing, pharmaceutical CDMO services, cGMP contract manufacturing, aerosol drug delivery, pressurized packaging manufacturing
Industry3 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pharmaceutical Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeTransaction Fee
Description

Formulated Solutions generates revenue through fee-for-service contract manufacturing agreements, where it develops and manufactures pharmaceutical, OTC, medical device, and consumer healthcare products on behalf of brand owners (marketing partners). Services span the full product lifecycle from formulation development and analytical testing through commercial manufacturing and packaging. Revenue is driven by volume of units produced, complexity of formulations, and breadth of services contracted.

formulatedsolutions.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details2 tiers
1Development and Feasibility Programs
ModelOtherBilling cadencePay-as-you-go
Notes

Small-scale feasibility batches supported for early concept testing, texture and elegance evaluation, and performance assessment before committing to full development or scale-up. Pricing negotiated per project scope.

formulatedsolutions.com
2Commercial Manufacturing Programs
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Most commercial programs begin at 50,000–75,000 units per SKU, scaling to tens of millions of units annually. Unit pricing varies by product format (aerosol, tube, nasal spray, etc.), formulation complexity, and packaging configuration.

formulatedsolutions.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1eN₂fused™
Description

Proprietary whipped delivery platform that infuses formulations with compressed gas microbubbles, creating whipped, aerated texture for creams, lotions and ointments.

formulatedsolutions.com
+2 more records
Core offering1 text field

Formulated Solutions is a full-service Contract Development and Manufacturing Organization (CDMO) providing end-to-end non-sterile pharmaceutical, OTC, medical device, and consumer healthcare product development and manufacturing on behalf of brand owner marketing partners. Services span formulation and analytical development, regulatory affairs, cGMP commercial manufacturing, and packaging across two U.S. facilities (Largo, FL and Cleveland, TN), supported by proprietary delivery platforms (eN₂fused™, cryO₂fused®, ZnOSpray™) and container closure systems including bag-on-valve, aerosol, metered dose nasal spray, and airless containers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 650 product success stories delivered across pharmaceutical and consumer healthcare markets
+4 more records
Product overview1 text field

Formulated Solutions is a Contract Development and Manufacturing Organization (CDMO) providing end-to-end pharmaceutical and consumer healthcare product development and manufacturing services. The company operates two US manufacturing facilities (Largo, FL and Cleveland, TN) totaling over 800,000 sq ft. Core offerings include proprietary delivery technologies (eN₂fused™ whipped delivery, cryO2fused® cryogenic delivery, ZnOSpray™ high-solid powder spray), container closure systems (bag-on-valve, aerosols, metered dose nasal sprays, airless containers), technology platforms (semi-solid and liquid manufacturing), and comprehensive services (formulation development, analytical development, manufacturing, regulatory affairs, and packaging). The company serves Rx therapeutics, OTC, personal care, and medical device market segments with cGMP production capabilities.

Product and service14 records
1eN₂fused™ Whipped Delivery Platform
CategoryProprietary Delivery Technology
Description

Proprietary whipped delivery technology that infuses formulations with compressed gas microbubbles to create whipped, aerated textures for creams, lotions, and ointments, enabling differentiated sensory experiences for pharmaceutical and consumer healthcare brand owners.

2cryO₂fused® Cryogenic Delivery Platform
CategoryProprietary Delivery Technology
Description

Patented cryogenic platform that creates an intense cooling sensation on the skin using cryogenically active micro-bubbles that burst on contact, usable in foams and sprays for skincare, pain relief, and personal care applications.

3ZnOSpray™ High Solid Powder Spray Platform
CategoryProprietary Delivery Technology
Description

Proprietary high-solid powder spray platform that reliably delivers high-solid-content powders (e.g., zinc oxide) without clogging or agglomeration, with applications in incontinence-associated dermatitis treatments, dry shampoos, and antifungal foot sprays.

4Bag-on-Valve (BoV) Container System
CategoryContainer Closure System
Description

Pressurized container system featuring a multi-layer laminate bag hermetically sealed inside a can with compressed gas, providing 360° dispensing, product protection from oxygen, and >99% evacuation rate.

5Aerosol Delivery Systems
CategoryContainer Closure System
Description

Pressurized aerosol delivery systems integrating can, valve, dip tube, actuator, formula concentrate, and propellant components for pharmaceutical and consumer health applications.

6Metered Dose Nasal Spray (MDNS) Systems
CategoryContainer Closure System
Description

Precision nasal delivery system providing pinpoint therapeutic delivery to nasal mucosa with controlled dosing for localized treatment, produced on a 9,000 sq ft high-speed suite capable of 185-200 units per minute.

7Airless Container Systems
CategoryContainer Closure System
Description

Vacuum-powered airless packaging system with rising barrier plate that prevents air intrusion, providing contamination protection, precise dosage, and >99% product evacuation for medical devices and NDA products.

8Semi-Solid Manufacturing Platform
CategoryTechnology Platform
Description

Development and manufacturing platform for semi-solid products including creams, gels, lotions, and ointments, with capabilities for high viscosity, high alcohol, and flammable formulations across 11 high-speed tube filling lines.

9Liquid Technologies Manufacturing Platform
CategoryTechnology Platform
Description

Master liquid product development and manufacturing platform for pharmaceuticals, OTC drugs, personal care, and cosmetics, with capabilities including tube filling (laminate, aluminum, monolayer), rollerballs, nasal spray pumps, bottles, jars, and pumps.

10Formulation & Process Development
CategoryCDMO Service
Description

Comprehensive formulation and process development services for aerosols, liquids, gels, creams, lotions, nasal sprays, and oral dose liquids, using an integrated QbD approach with scalable manufacturing design.

11Analytical Development Services
CategoryCDMO Service
Description

Full-service analytical method development, verification, validation, and transfers, including chromatography (LC, GC, GC-MS, FTIR), product characterization, and atomic absorption spectrometry.

12cGMP Commercial Manufacturing
CategoryCDMO Service
Description

Full-turnkey cGMP commercial manufacturing with capabilities including water-based, anhydrous, and alcohol blending, pressurized bag-on-valve and aerosol packaging, tube filling, and metered dose nasal spray production, with flexible batch sizes from 25 to 4,000 gallons across both Largo, FL and Cleveland, TN facilities.

13Regulatory Affairs Services
CategoryCDMO Service
Description

Regulatory strategy and compliance services including CMC management, CTD development, FDA submissions (IND/NDA), and support for OTC, Rx, medical device, and global regulatory pathways.

14Packaging Engineering and Manufacturing
CategoryCDMO Service
Description

Packaging engineering and manufacturing services including aerosol innovations, bag-on-valve, pressurized powder sprays, nasal delivery, and liquid/semi-solid filling in bottles, jars, and tubes, with modular production lines for rapid reconfiguration.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global CDMO offering formulation, development, and manufacturing services across oral, sterile injectable, biologics, and consumer health formats. Most directly comparable as a full-service pharmaceutical and consumer healthcare CDMO competing for the same brand-owner programs.

TypeDirect peer
Description

Specializes in primary packaging, drug delivery systems, and contract manufacturing for injectables and consumer health. Comparable through its expertise in container closure systems (analogous to Formulated Solutions' bag-on-valve, metered dose, and airless container offerings) and its CDMO services for pharma and consumer health customers.

TypeDirect peer
Description

Provides drug delivery systems, dispensing solutions, and contract development services for pharma, OTC, and personal care. Direct comparable through nasal spray pumps, aerosol valves, and bag-on-valve technologies that overlap with Formulated Solutions' container closure and pressurized packaging capabilities.

TypeDirect peer
Description

Global CDMO focused on inhalation, transdermal, and intradermal drug delivery, plus injectable manufacturing. Overlaps with Formulated Solutions in pressurized metered dose and topical drug delivery for pharma and consumer health brand owners.

5Recipharm
TypeDirect peer
Description

European-headquartered CDMO offering development and manufacturing across solid, semi-solid, and sterile dosage forms. Comparable as a multi-site CDMO serving pharma and consumer health customers with formulation, analytical, and commercial manufacturing services.

TypeDirect peer
Description

Global CDMO providing drug development, manufacturing, and packaging services across solid dose, sterile, and clinical supply. Comparable in offering integrated services from development through commercial packaging to pharmaceutical and consumer health brand owners.

TypeDirect peer
Description

U.S.-based CDMO focused on small-molecule oral solids, liquids, and semi-solids for pediatric, psychiatric, and consumer health products. Closely comparable in scale and specialty dosage form focus, including topicals and liquids, serving brand-owner customers.

TypeDirect peer
Description

Large U.S. CDMO and generic manufacturer with FDA-approved facilities producing inhalation, ophthalmic, and liquid dosage forms. Comparable through its consumer healthcare manufacturing scale and its pressurized/aerosol product capabilities.

TypeDirect peer
Description

U.S. contract manufacturer specializing in Wurster coating, hot-melt extrusion, and modified-release oral dose forms. Comparable as a smaller, specialty U.S. CDMO with proprietary processing capabilities serving pharma brand owners.

TypeBroad incumbent
Description

European-headquartered CDMO offering development and manufacturing for pharma, dietary supplements, and consumer health across solid, semi-solid, and liquid dosage forms. Comparable as a broader incumbent with overlapping topical, liquid, and consumer health CDMO services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance19 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Formulated Solutions

Pharmaceutical Contract Manufacturingformulatedsolutions.com

Formulated Solutions is a US-based non-sterile CDMO providing end-to-end formulation development, cGMP manufacturing, and packaging services for pharmaceutical, OTC, medical device, and consumer healthcare brand owners across two facilities totaling 800,000+ sq ft.

What Formulated Solutions does

Formulated Solutions is a US-based, non-sterile contract development and manufacturing organization (CDMO) founded in 1999 and headquartered in Largo, Florida. The company provides end-to-end services for pharmaceutical, over-the-counter (OTC), medical device, and consumer healthcare brand owners, spanning formulation and analytical development, regulatory affairs, cGMP manufacturing, and packaging. Its product portfolio covers topical creams, gels and ointments, nasal sprays, oral dose liquids, aerosols, bag-on-valve systems, and high-solid powder sprays across Rx, OTC, personal care, and FDA Class 1/2 medical device categories.

The company's technology base rests on three proprietary delivery platforms—eN₂fused™ (whipped microbubble delivery), cryO₂fused® (cryogenic cooling delivery), and ZnOSpray™ (high-solid powder spray)—complemented by container closure systems and high-speed production lines reaching 185–200 units per minute on metered dose nasal sprays. Operating capacity exceeds 650 million units annually across more than 800,000 sq ft of combined cGMP manufacturing and warehousing, anchored by a 220,000 sq ft flagship in Largo, FL and a 455,000 sq ft secondary site in Cleveland, TN acquired in 2023. The company is regulated by FDA and 16 additional global authorities and holds ISO 9001, ISO 13485, ISO 22716, ISO 14001, and ISO 45001 certifications.

Formulated Solutions generates revenue on a fee-for-service contract manufacturing basis, with commercial programs typically requiring minimum order quantities of 50,000–75,000 units per SKU and scaling to tens of millions of units annually under multi-year agreements. The company sells exclusively through a B2B enterprise model targeting brand owners, with go-to-market driven by direct field sales (led by a Chief Commercial Officer and regional representatives) supplemented by industry trade shows (BIO, CPHI, Cosmoprof), thought leadership webinars, and content marketing. Customers include seven of the world's top 12 consumer healthcare companies, and products reach more than 45 countries. The company has been controlled by Linden Capital Partners since 2021, when founder Eric Dann sold a controlling share while retaining a board seat.

Formulated Solutions firmographics

Firmographics
Name
Formulated Solutions
Legal name
Formulated Solutions, LLC
Website
https://formulatedsolutions.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
251–500 employees
Short description
Formulated Solutions is a US-based non-sterile CDMO providing end-to-end formulation development, cGMP manufacturing, and packaging services for pharmaceutical, OTC, medical device, and consumer healthcare brand owners across two facilities totaling 800,000+ sq ft.
Ownership category
akta.pro rank

Formulated Solutions industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (3391)
SIC
Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Contract development manufacturing
  • Pharmaceutical CDMO services
  • CGMP contract manufacturing
  • Aerosol drug delivery
  • Pressurized packaging manufacturing

Where Formulated Solutions is headquartered

Location

Headquarters

HQ city
Largo
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Formulated Solutions business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Formulated Solutions generates revenue through fee-for-service contract manufacturing agreements, where it develops and manufactures pharmaceutical, OTC, medical device, and consumer healthcare products on behalf of brand owners (marketing partners). Services span the full product lifecycle from formulation development and analytical testing through commercial manufacturing and packaging. Revenue is driven by volume of units produced, complexity of formulations, and breadth of services contracted.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goDevelopment and Feasibility Programs
Unit PricingMulti-year contractCommercial Manufacturing Programs

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Formulated Solutions product offering

Product offering

Core offering

Formulated Solutions is a full-service Contract Development and Manufacturing Organization (CDMO) providing end-to-end non-sterile pharmaceutical, OTC, medical device, and consumer healthcare product development and manufacturing on behalf of brand owner marketing partners. Services span formulation and analytical development, regulatory affairs, cGMP commercial manufacturing, and packaging across two U.S. facilities (Largo, FL and Cleveland, TN), supported by proprietary delivery platforms (eN₂fused™, cryO₂fused®, ZnOSpray™) and container closure systems including bag-on-valve, aerosol, metered dose nasal spray, and airless containers.

Product overview

Formulated Solutions is a Contract Development and Manufacturing Organization (CDMO) providing end-to-end pharmaceutical and consumer healthcare product development and manufacturing services. The company operates two US manufacturing facilities (Largo, FL and Cleveland, TN) totaling over 800,000 sq ft. Core offerings include proprietary delivery technologies (eN₂fused™ whipped delivery, cryO2fused® cryogenic delivery, ZnOSpray™ high-solid powder spray), container closure systems (bag-on-valve, aerosols, metered dose nasal sprays, airless containers), technology platforms (semi-solid and liquid manufacturing), and comprehensive services (formulation development, analytical development, manufacturing, regulatory affairs, and packaging). The company serves Rx therapeutics, OTC, personal care, and medical device market segments with cGMP production capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • eN₂fused™: Proprietary whipped delivery platform that infuses formulations with compressed gas microbubbles, creating whipped, aerated texture for creams, lotions and ointments.
  • cryO₂fused®
  • ZnOSpray™

Products and services

  • eN₂fused™ Whipped Delivery Platform Proprietary whipped delivery technology that infuses formulations with compressed gas microbubbles to create whipped, aerated textures for creams, lotions, and ointments, enabling differentiated sensory experiences for pharmaceutical and consumer healthcare brand owners.
  • cryO₂fused® Cryogenic Delivery Platform Patented cryogenic platform that creates an intense cooling sensation on the skin using cryogenically active micro-bubbles that burst on contact, usable in foams and sprays for skincare, pain relief, and personal care applications.
  • ZnOSpray™ High Solid Powder Spray Platform Proprietary high-solid powder spray platform that reliably delivers high-solid-content powders (e.g., zinc oxide) without clogging or agglomeration, with applications in incontinence-associated dermatitis treatments, dry shampoos, and antifungal foot sprays.
  • Bag-on-Valve (BoV) Container System Pressurized container system featuring a multi-layer laminate bag hermetically sealed inside a can with compressed gas, providing 360° dispensing, product protection from oxygen, and >99% evacuation rate.
  • Aerosol Delivery Systems Pressurized aerosol delivery systems integrating can, valve, dip tube, actuator, formula concentrate, and propellant components for pharmaceutical and consumer health applications.
  • Metered Dose Nasal Spray (MDNS) Systems Precision nasal delivery system providing pinpoint therapeutic delivery to nasal mucosa with controlled dosing for localized treatment, produced on a 9,000 sq ft high-speed suite capable of 185-200 units per minute.
  • Airless Container Systems Vacuum-powered airless packaging system with rising barrier plate that prevents air intrusion, providing contamination protection, precise dosage, and >99% product evacuation for medical devices and NDA products.
  • Semi-Solid Manufacturing Platform Development and manufacturing platform for semi-solid products including creams, gels, lotions, and ointments, with capabilities for high viscosity, high alcohol, and flammable formulations across 11 high-speed tube filling lines.
  • Liquid Technologies Manufacturing Platform Master liquid product development and manufacturing platform for pharmaceuticals, OTC drugs, personal care, and cosmetics, with capabilities including tube filling (laminate, aluminum, monolayer), rollerballs, nasal spray pumps, bottles, jars, and pumps.
  • Formulation & Process Development Comprehensive formulation and process development services for aerosols, liquids, gels, creams, lotions, nasal sprays, and oral dose liquids, using an integrated QbD approach with scalable manufacturing design.
  • Analytical Development Services Full-service analytical method development, verification, validation, and transfers, including chromatography (LC, GC, GC-MS, FTIR), product characterization, and atomic absorption spectrometry.
  • cGMP Commercial Manufacturing Full-turnkey cGMP commercial manufacturing with capabilities including water-based, anhydrous, and alcohol blending, pressurized bag-on-valve and aerosol packaging, tube filling, and metered dose nasal spray production, with flexible batch sizes from 25 to 4,000 gallons across both Largo, FL and Cleveland, TN facilities.
  • Regulatory Affairs Services Regulatory strategy and compliance services including CMC management, CTD development, FDA submissions (IND/NDA), and support for OTC, Rx, medical device, and global regulatory pathways.
  • Packaging Engineering and Manufacturing Packaging engineering and manufacturing services including aerosol innovations, bag-on-valve, pressurized powder sprays, nasal delivery, and liquid/semi-solid filling in bottles, jars, and tubes, with modular production lines for rapid reconfiguration.

Quantifiable outcome

  • Over 650 product success stories delivered across pharmaceutical and consumer healthcare markets
  • +4 more outcomes

Companies that use Formulated Solutions

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Formulated Solutions technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Formulated Solutions partnerships and signals

Strategic signal

Scale indicators11 records

Recent moves7 records

Expansion highlights5 records

Formulated Solutions competitors and assessment

Company assessment

Direct peers

  • Catalent: Global CDMO offering formulation, development, and manufacturing services across oral, sterile injectable, biologics, and consumer health formats. Most directly comparable as a full-service pharmaceutical and consumer healthcare CDMO competing for the same brand-owner programs.
  • West Pharmaceutical Services: Specializes in primary packaging, drug delivery systems, and contract manufacturing for injectables and consumer health. Comparable through its expertise in container closure systems (analogous to Formulated Solutions' bag-on-valve, metered dose, and airless container offerings) and its CDMO services for pharma and consumer health customers.
  • Aptar Pharma: Provides drug delivery systems, dispensing solutions, and contract development services for pharma, OTC, and personal care. Direct comparable through nasal spray pumps, aerosol valves, and bag-on-valve technologies that overlap with Formulated Solutions' container closure and pressurized packaging capabilities.
  • Kindeva Drug Delivery: Global CDMO focused on inhalation, transdermal, and intradermal drug delivery, plus injectable manufacturing. Overlaps with Formulated Solutions in pressurized metered dose and topical drug delivery for pharma and consumer health brand owners.
  • Recipharm: European-headquartered CDMO offering development and manufacturing across solid, semi-solid, and sterile dosage forms. Comparable as a multi-site CDMO serving pharma and consumer health customers with formulation, analytical, and commercial manufacturing services.
  • PCI Pharma Services: Global CDMO providing drug development, manufacturing, and packaging services across solid dose, sterile, and clinical supply. Comparable in offering integrated services from development through commercial packaging to pharmaceutical and consumer health brand owners.
  • Halo Pharma: U.S.-based CDMO focused on small-molecule oral solids, liquids, and semi-solids for pediatric, psychiatric, and consumer health products. Closely comparable in scale and specialty dosage form focus, including topicals and liquids, serving brand-owner customers.
  • Nephron Pharmaceuticals: Large U.S. CDMO and generic manufacturer with FDA-approved facilities producing inhalation, ophthalmic, and liquid dosage forms. Comparable through its consumer healthcare manufacturing scale and its pressurized/aerosol product capabilities.
  • Coating Place: U.S. contract manufacturer specializing in Wurster coating, hot-melt extrusion, and modified-release oral dose forms. Comparable as a smaller, specialty U.S. CDMO with proprietary processing capabilities serving pharma brand owners.

Broad incumbents

  • Aenova Group: European-headquartered CDMO offering development and manufacturing for pharma, dietary supplements, and consumer health across solid, semi-solid, and liquid dosage forms. Comparable as a broader incumbent with overlapping topical, liquid, and consumer health CDMO services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Formulated Solutions social profiles

Digital presence

Formulated Solutions compliance and trust

Trust signal

Compliance19 records

Formulated Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Formulated Solutions leadership team

Management profile

Number of profiles

Profiles13 records

Formulated Solutions funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Formulated Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Formulated Solutions

What does Formulated Solutions do?

Formulated Solutions is a full-service Contract Development and Manufacturing Organization (CDMO) providing end-to-end non-sterile pharmaceutical, OTC, medical device, and consumer healthcare product development and manufacturing on behalf of brand owner marketing partners. Services span formulation and analytical development, regulatory affairs, cGMP commercial manufacturing, and packaging across two U.S. facilities (Largo, FL and Cleveland, TN), supported by proprietary delivery platforms (eN₂fused™, cryO₂fused®, ZnOSpray™) and container closure systems including bag-on-valve, aerosol, metered dose nasal spray, and airless containers.

Is Formulated Solutions a public or private company?

Formulated Solutions is a private company. It is classified as private equity controlled and is currently operating.

When was Formulated Solutions founded?

Formulated Solutions was founded in 1999. It employs 251 to 500 people.

Where is Formulated Solutions based?

Formulated Solutions is headquartered in Largo, United States, in the North America region.

How does Formulated Solutions make money?

One revenue line is on record: contract Manufacturing Services.

Who are Formulated Solutions's main competitors?

Direct peers on record are Catalent, West Pharmaceutical Services, Aptar Pharma, Kindeva Drug Delivery, Recipharm, PCI Pharma Services, Halo Pharma, Nephron Pharmaceuticals and Coating Place. Aenova Group is listed as a broad incumbent.

Does Formulated Solutions have an API?

No public API is recorded for Formulated Solutions.

What industry is Formulated Solutions in?

Formulated Solutions's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
스타트업엔(StartupN)뷰센스, LA 뷰티 포럼서 미국 서부 세일즈 네트워크 구축VUSSENS Inc., a subsidiary of New En AI, expanded its US sales network at a LA beauty industry forum, meeting executives from Murad, Flexport, and Formulated Solutions. The company plans to extend its operations to the US South and Midwest, and also target Japan, Europe, and Southeast Asia.BioSpaceChannel Methods Launches MethodsSignals for Life Sciences Business DevelopmentChannel Methods launched MethodsSignals, an AI-enabled commercial intelligence service for life sciences teams. Formulated Solutions, an early customer, reduced its insight-to-first-contact timeline by over 90% during the pilot. The service also added dozens of senior decision-makers to its CRM weekly.PR NewswireThe Power of Less: Winning with Asset-Light Manufacturing, Upcoming Webinar Hosted by XtalksXtalks, a provider of educational webinars for the life science and healthcare sectors, is hosting a free webinar on January 27, 2026 titled "The Power of Less: Winning with Asset-Light Manufacturing." The webinar will feature M. Scott Carpenter, Vice President of Marketing & Partner Innovation at Formulated Solutions, who will discuss how companies can reduce capital expenditure by partnering with Contract Development and Manufacturing Organizations (CDMOs) to achieve flexibility, scalability, and faster market entry. The session is targeted at pharmaceutical, biotechnology, and healthcare industry professionals seeking to learn about asset-light manufacturing strategies without building internal production infrastructure.Drug Development and DeliveryFormulated Solutions Adds Third GMP Aerosol Line to Deliver Fill Flexibility, Accelerate Delivery Timelines & Increase Production CapacityFormulated Solutions, a contract development and manufacturing organization, has installed a third GMP aerosol production line at its Cleveland facility, fully automated from filling through case packing. The line uses a mass flow filler, automated leak detection, and optical character recognition verification, enabling sequential filling of two bulk intermediates and two propellant blends. The company said the addition boosts capacity for medicated topical aerosols, including sunscreens and analgesics.ContractpharmaPharma Companies Turn to U.S. CDMOs for SolutionsPharmaceutical companies are increasingly partnering with U.S. contract development and manufacturing organizations (CDMOs) to navigate supply chain disruptions and economic volatility. Formulated Solutions, a CDMO, recently acquired a 455,000-square-foot FDA-approved facility in Cleveland, TN, and commits 30% of its R&D to speculative development for partner growth.BioSpaceFormulated Solutions Signs Agreement to Acquire 455,000ft2 US FDA Approved Drug Production SiteFormulated Solutions has signed an agreement to acquire a 455,000 square foot FDA-approved pharmaceutical production facility in Cleveland, Tennessee. This acquisition is intended to expand the company's manufacturing capacity for consumer healthcare products, including aerosols and nasal sprays, to meet current commercial demand and support future innovation pipelines.PR NewswireFormulated Solutions Signs Agreement to Acquire 455,000ft2 US FDA Approved Drug Production SiteFormulated Solutions agreed to acquire a 455,000 ft2 FDA-approved drug production facility in Cleveland, TN, expanding its pharma and consumer healthcare manufacturing capacity. The acquisition strengthens capabilities in topicals, metered dose nasal sprays, and pressurized packaging, supporting current demand and future innovation.PR NewswireFormulated Solutions Taps John Maddox for Newly Created COO PositionFormulated Solutions, a Consumer Healthcare Contract Development and Manufacturing Organization (CDMO), appointed John Maddox as its first Chief Operating Officer effective February 21, 2022. Maddox brings over seven years of experience from Bayer Consumer Healthcare and most recently served as General Manager at Catalent Pharma Solutions. In his new role, he will oversee daily global operations, supply chain, safety, and engineering functions for the company, which produces over 650 million units annually across OTC, Rx, Medical Device, and aerosol formulations.PR NewswireFormulated Solutions Completes Large Scale Footprint, Capacity, and Capabilities ExpansionFormulated Solutions has completed its largest infrastructure expansion project in Largo, Florida, significantly increasing its manufacturing footprint and capacity for pharmaceutical and consumer healthcare products. The facility upgrades include 30,000 square feet of new space, enhanced blending capabilities, and a dedicated production line for nasal sprays capable of producing 200 units per minute.